-
FDA approves ADHD drug for adolescents
PHILADELPHIA — The Food and Drug Administration has approved an attention deficit hyperactivity disorder drug for use in adolescents.
British drug maker Shire announced Monday the approval of Vyvanse (lisdexamfetamine dimesylate) capsules for patients aged 13 to 17. The drug was already approved for children ages 6 years to 12 years and adults.
-
Study: Mild asthma patients may be overusing drug combinations
PHOENIX — Most patients with mild persistent asthma overuse a drug combination despite an apparent lack of added medical benefit, according to a new study by pharmacy benefit manager Medco.